TwoOncDocs

539 posts

TwoOncDocs banner
TwoOncDocs

TwoOncDocs

@TwoOncDocs

🩸 a podcast about heme/onc for health care providers | ☕️ short high yield episodes to supplement your board review resources | @SamArmstrongMD @DrKarineTawagi

Katılım Haziran 2022
1.7K Takip Edilen4.3K Takipçiler
TwoOncDocs retweetledi
Karine Tawagi MD
Karine Tawagi MD@DrKarineTawagi·
Looking forward to hosting #TumorBoardTuesday on March 24 at 7PM CST w/ @PGrivasMDPhD discussing peri-operative therapy in Bladder Cancer including updates from #ASCOGU26 💫 @TwoOncDocs
#TumorBoardTuesday@TumorBoardTues

@JackieAredoMD @riess_md @IntegrityCE @DrSanjayPopat @stephanieplsaw @StephenVLiu @LeXiuning @NarjustFlorezMD @SukiPaddaMD @JoelNealMD @Latinamd @jillfeldman4 @Exon20Group @drgandara @LeciaSequist @marinagarassino @peters_solange #TumorBoardTuesday 😀That was SUCH an interesting case & discussion 🙏thank you so much @riess_md and @JackieAredoMD for the amazing education 🧑‍🏫 And join us on @TumorBoardTues in 2 weeks, March 24, 2026 when we have @PGrivasMDPhD back with @DrKarineTawagi to🗣️bladder cancer‼️

English
1
5
12
981
TwoOncDocs retweetledi
Oncology Brothers
Oncology Brothers@OncBrothers·
Wow… #ASCO26 is in < 3 months! We are moderating 2 satellite 🗣️ and we would love to see you there. 1. Onc Board Review w/ @TwoOncDocs on May 28 (Thursday afternoon) 2. Adv in Onc: 30 minutes 🗣️ each on GI, GU, Lung, & Breast Ca on May 30 (Saturday evening) #OncTwitter
Oncology Brothers tweet media
English
4
10
23
5.3K
TwoOncDocs retweetledi
OncUpdates
OncUpdates@OncUpdates·
🔥 Exciting upcoming events w/@OncBrothers 📅 Fellows Board Review w/@TwoOncDocs | 5.28.2026 | Chicago 🩺 📅 @ASCO Annual Meeting | 5.30.2026 | Chicago 🌟 📅 Upstate NY Cancer Symposium (CME) | 6.20.2026 | Rochester, NY 🎓 📌 Mark your calendars! #OncTwitter #MedEd #MedTwitter
OncUpdates tweet media
English
0
3
6
344
TwoOncDocs retweetledi
Karine Tawagi MD
Karine Tawagi MD@DrKarineTawagi·
📣 calling all artists for the @ASCO SEP Digital Edition Cover Art Contest! 🧑‍🎨🎨 The winner of the contest will have their artwork featured on the cover Individuals or groups can submit artwork by April 6, 2026, at 11:59 EST app.smartsheet.com/b/form/019c777… @TwoOncDocs
GIF
English
1
8
18
2.9K
TwoOncDocs
TwoOncDocs@TwoOncDocs·
This week’s special guest @MarcCarrier1 , Tier 1 Clinical Research Chair in VTEs & Cancer from U of Ottawa 🇨🇦 joins us! 🩸 In part 1, we discuss the work-up & Tx of VTEs & CA, inc. types of anti-coag, duration & more! What is a preferred dosing for Enoxaparin for VTE in CA?
English
0
1
6
576
TwoOncDocs retweetledi
Karine Tawagi MD
Karine Tawagi MD@DrKarineTawagi·
Big morning for Belzutifan🎉#ASCOGU26 #LITESPARK011 combo w/ Lenva vs Cabo in 2L+ s/p IO in mRCC (55% prior TKI) ➕ PFS, ORR, immature OS, 20 pts w/ CR ⚠️15% hypoxia, 2/3 DR TKI, 1/3 DR Belz #LITESPARK022 adj belzu/pembro vs pembro x1yr ➕DFS, immature OS ⚠️ ~12% pts PRBC/ESA
Karine Tawagi MD tweet mediaKarine Tawagi MD tweet mediaKarine Tawagi MD tweet mediaKarine Tawagi MD tweet media
English
2
14
36
1.8K
TwoOncDocs retweetledi
Karine Tawagi MD
Karine Tawagi MD@DrKarineTawagi·
Groundbreaking KN-B15 for EVP in cis-eligible MIBC 👤 most T3/T4a, 90% pure urothelial 🎖️ EFS HR 0.53, OS HR 0.65, pCR 55.8% vs 32.5% ⚠️¾ grade 3 TEAE, 25% stopped NA EVP & 28.6% adj EVP d/t TEAE ‼️36% neuropathy, 63% skin, 23% 👁️ ❓how many got IO in control arm
Karine Tawagi MD tweet mediaKarine Tawagi MD tweet mediaKarine Tawagi MD tweet mediaKarine Tawagi MD tweet media
English
1
11
27
1.1K
TwoOncDocs
TwoOncDocs@TwoOncDocs·
This week’s episode we did a preview of data for #ASCOGU26 For fellows, the landscape of MIBC continues to evolve quickly with #KNB15 to come on peri-operative EVP in cisplatin ELIGIBLE pts to be presented Friday AM! Good luck to all taking onc ITE this week! @HemOncFellows
Karine Tawagi MD@DrKarineTawagi

Beautiful day to be heading to SF ✈️🏔️ for #ASCOGU26 Looking forward to exciting data over the next 3 days -PCa: BRCCAway OS, PEACE-2, PSMAddition, PAnTHA (Ac-225) -UC: KN-B15, RETAIN, RC48G001, utDNA in NIAGARA, KN905 path & DFS -RCC: LITESPARK-011, 022, 024, CYTOSHRINK

English
0
2
11
1.3K
TwoOncDocs
TwoOncDocs@TwoOncDocs·
@MamthaB @HemOncFellows A couple notes: erdafitinib is not approved in MIBC only 2L mUC, and SG is no longer approved in mUC, FDA label was revoked in 2024. Boards may lag but MIBC standards are gem/cis/durba for cis-eligible & EVP for cis-ineligible
English
2
1
9
565
TwoOncDocs retweetledi
Mamtha Balla, MD, MPH, FACP
Mamtha Balla, MD, MPH, FACP@MamthaB·
@TwoOncDocs Perfect podcast for ITE review and revision! 🎧📚 I love listening every time — they break down complex oncology topics so clearly and make the high-yield board points stick 💡🔥 Thank you for putting this together and sharing your time and expertise! 🙌👏 #Oncology
English
0
1
5
507
TwoOncDocs
TwoOncDocs@TwoOncDocs·
We did a new topic this week! Rad Onc 101 with @RadOncTalks ☢️ In part 1, we reviewed types of RT, how it works, the patient experience & common AEs In part 2 we will review duration & fractionation schemes, indications for RT & more @HemOncFellows
TwoOncDocs tweet media
English
1
4
14
1.5K
TwoOncDocs retweetledi
Ronak H. Mistry, DO
Ronak H. Mistry, DO@rmistry91·
Proud to share that our latest med ed article is now published! Here, we show how heme/onc fellowship didactic curricula are organized at programs across the country. Goal: Let's continue to make heme/onc fellowship education better and better! Link: rdcu.be/e2yMw
Ronak H. Mistry, DO tweet media
English
0
7
22
1.8K
TwoOncDocs
TwoOncDocs@TwoOncDocs·
This week’s episode we are so excited to welcome @chadinabhan, host of Healthcare Unfiltered. We discuss why oncology, our career paths, different career paths in hematology and oncology, contract & negotiation considerations & tips to search for a job ✨ @HemOncFellows
TwoOncDocs tweet media
English
1
4
13
817
TwoOncDocs retweetledi
Karine Tawagi MD
Karine Tawagi MD@DrKarineTawagi·
‼️abstract titles are out for #ASCOGU26 📆 schedule by day & looking forward to: -PCa: BRCCAway OS, PEACE-2, PSMAddition, PAnTHA (Ac-225) -UC: most importantly KN-B15, but also RETAIN, RC48G001, utDNA in NIAGARA, KN905 path & DFS -RCC: LITESPARK-011, 022, 024, CYTOSHRINK
Karine Tawagi MD tweet mediaKarine Tawagi MD tweet mediaKarine Tawagi MD tweet media
English
2
29
73
6.8K
TwoOncDocs
TwoOncDocs@TwoOncDocs·
New topic this week! We are so excited to welcome very special guest Dr. Krystle Zuniga, board-certified specialist in oncology nutrition 🍎 In part 1, we discuss info + myths in oncology nutrition - cancer feeds sugar, fiber, estrogen, supplements, fasting… @HemOncFellows
TwoOncDocs tweet media
English
0
2
16
836
TwoOncDocs
TwoOncDocs@TwoOncDocs·
The answer is A) FL is usually + for CD19, CD20, CD79a), CD21, and CD10 (60%) and lack expression of CD5, CD43 (most cases), and CD11c. CD23 expression is variable. BCL2 protein is strongly positive in almost all grade 1/2 tumors
English
0
0
0
124
TwoOncDocs
TwoOncDocs@TwoOncDocs·
Happy New Year! We are back with 2026 updates on Follicular Lymphoma Which of the following are typical positive immunophenotype markers in FL? @HemOncFellows
English
1
1
4
470

Keşfet

@PGrivasMDPhD @OncBrothers @ASCO @MarcCarrier1 @apolo_andrea @UroDocAsh @DrKarineTawagi @AlanBryce9